Completed
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine
NCT00118625
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +1 more
- Locations
-
- Allied Research International Inc. Mississauga, Ontario, Canada